Intelligent Investor

4DMedical Limited (ASX: 4DX) - Announcements

- Current share price for 4DX : $0.600

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$235 Application for quotation of securities - 4DX 5 Apr 2024 2:36PM $0.628 $0.600 $0.615 fallen by 4.38%
$235 Notification regarding unquoted securities - 4DX 20 Mar 2024 2:33PM $0.655 $0.600 $0.615 fallen by 8.40%
$235 U.S. budget pushes for action on screening for Veterans 11 Mar 2024 9:19AM $0.785 $0.600 $0.615 fallen by 23.57%
$235 Cleansing Notice 8 Mar 2024 3:34PM $0.805 $0.600 $0.615 fallen by 25.47%
$235 Change of Director's Interest Notice 8 Mar 2024 3:28PM $0.805 $0.600 $0.615 fallen by 25.47%
$235 Change of Director's Interest Notice 8 Mar 2024 3:27PM $0.805 $0.600 $0.615 fallen by 25.47%
$235 Change of Director's Interest Notice 8 Mar 2024 3:25PM $0.805 $0.600 $0.615 fallen by 25.47%
$235 Application for quotation of securities - 4DX 8 Mar 2024 3:23PM $0.805 $0.600 $0.615 fallen by 25.47%
$235 S&P DJI Announces March 2024 Quarterly Rebalance 1 Mar 2024 5:03PM $0.690 $0.600 $0.615 fallen by 13.04%
$235 4DMedical secures participation in pivotal burn pit research 1 Mar 2024 9:11AM $0.665 $0.600 $0.615 fallen by 9.77%
$235 1H FY2024 Investor Presentation 28 Feb 2024 9:13AM $0.650 $0.600 $0.615 fallen by 7.69%
$235 4DMedical reports positive 1H FY2024 results 28 Feb 2024 9:12AM $0.650 $0.600 $0.615 fallen by 7.69%
$235 Appendix 4D and Half-Year Report 28 Feb 2024 9:11AM $0.650 $0.600 $0.615 fallen by 7.69%
$235 Imbio secures research agreement with US Dept of Vet Affairs 27 Feb 2024 9:04AM $0.645 $0.600 $0.615 fallen by 6.98%
$235 4DMedical signs distribution agreement with Blackford 26 Feb 2024 9:10AM $0.635 $0.600 $0.615 fallen by 5.51%
$235 Quarterly Activity Report and Appendix 4C for Q2 FY2024 31 Jan 2024 9:16AM $0.620 $0.600 $0.615 fallen by 3.23%
$235 Change of Director's Interest Notice 24 Jan 2024 10:15AM $0.650 $0.600 $0.615 fallen by 7.69%
$235 Change of Director's Interest Notice 24 Jan 2024 10:13AM $0.650 $0.600 $0.615 fallen by 7.69%
$235 Notification regarding unquoted securities - 4DX 24 Jan 2024 10:03AM $0.650 $0.600 $0.615 fallen by 7.69%
$235 Top 20 optionholders and distribution schedule 23 Jan 2024 3:52PM $0.640 $0.600 $0.615 fallen by 6.25%
$235 Application for quotation of securities - 4DX 23 Jan 2024 3:50PM $0.640 $0.600 $0.615 fallen by 6.25%
$235 Results of Meeting 22 Jan 2024 12:07PM $0.650 $0.600 $0.615 fallen by 7.69%
$235 EGM presentation and Chair's address 22 Jan 2024 9:05AM $0.620 $0.600 $0.615 fallen by 3.23%
$235 4DMedical and Philips formalise MOU with Teaming Agreement 22 Jan 2024 9:01AM $0.620 $0.600 $0.615 fallen by 3.23%
$235 4DMedical webinar with Dr David Shulkin 15 Jan 2024 4:41PM $0.625 $0.600 $0.615 fallen by 4%

1 - 25 of 294 results

Page 1 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.